Not provided
Not provided
Not provided
Not provided
changes in patient care that move them further away from the inclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies.Patients may be included if they present with acute respiratory failure related to blunt chest trauma.The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of Positive End Expiratory Pressure (PEEP) during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the current care.
This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies. Patients may be included if they are admitted to intensive care unit or continuing care unit and present with acute respiratory failure related to blunt chest trauma. We will not include patients with another indication for non-invasive ventilation, immediately needing invasive ventilation, a contraindication to non invasive ventilation or an estimated length of stay less than or equal to 48 hours.
Both groups will be treated with non-ivasive ventilation according to the medical prescription. The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of PEEP during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the usual care. The other non-invasive ventilation settings will be chosen with the same method in both groups.
The main endpoint will be the PaO2/FiO2 ratio (Arterial oxygen pressure / inspired fraction of oxygen) after 30 min of non-invasive ventilation treatment. This ratio is the best reflection of the patient oxygenation and currently used for respiratory therapies studies.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental | Experimental | The intervention group will benefit from the physiotherapist's use of lung ultrasound for the PEEP adjustment during the first NIV session. |
|
| Control | Active Comparator | The conventional group will benefit from the NIV under the current terms. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lung Ultrasound for PEEP setting | Other | NIV is started and adjusted by the physiotherapist. For the adjustment of PEEP, the ultrasound probe is placed on the thorax, facing the intercostal space having obtained the highest score during the initial LUS (synonym of the worst pulmonary aeration) and the images observed in real time. PEEP is increased until the physiotherapist cannot see any additional benefit on pulmonary aeration or appearance of a patient discomfort or an increasing of air leaks. |
| Measure | Description | Time Frame |
|---|---|---|
| PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups | PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups. This PaO2/FiO2 ratio is now the benchmark for qualifying the severity of the respiratory impairment or measuring the response to a mechanical ventilation strategy aimed at improving oxygenation. | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| Measure | Description | Time Frame |
|---|---|---|
| Comparaison of the Lung Ultrasound Score (LUS) in both groups | Comparaison of the Lung Ultrasound Score (LUS) in both groups. The LUS ranges from 0 to 36. Rib cage is divided into 12 areas (6 for each side) and each area is assessed according to the following scale: 0: Normal aeration corresponding to presence of lung sliding with A lines or fewer than two isolated B lines
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UH of Montpellier | Montpellier | Montpellier | 34295 | France |
Not provided
open-labeled, controlled, randomized study
Not provided
Not provided
Not provided
Not provided
|
| Non invasive ventilation session | Procedure | The session will be done via a mouthpiece preferably, or a face mask if it is impossible for the patient to close their mouth properly or to hold the mouthpiece. The duration of the NIV session will be defined by the prescribing doctor (usually between 30 and 60 minutes), without being able to be less than 30 minutes. The session will be stopped in the event of the appearance of one of the contraindications to NIV mentioned above. |
|
| Arterial blood gas | Biological | Arterial blood gas will be done at inclusion, at Visit 1 (at the 30th minute from the start of the 1st Non-invasive ventilation session) and at Visit 2 (at the 60th minute from the start of the 1st Non-invasive ventilation session) in both groups of patients in order to calculate the Pa02/Fi02 ratio. |
|
| Interview on pain and comfort | Other | The investigator physiotherapist interviews the participant to measure pain and comfort scores using a visual analogue scale (score from 0 to 10). |
|
| at the 30th minute from the start of the 1st Non-invasive ventilation session |
| Comparaison of the PEEP value set at the start of the non-invasive ventilation session | Comparaison of the PEEP value set (in cmH2O) in both groups | At the start of the non-invasive ventilation session |
| Comparaison of the confort value in both groups | Comparaison of the confort value in both groups using the Confort Visual Analog scale (from 0 to 10) | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| Comparaison of the pain value in both groups | Comparaison of the pain value in both groups using the Pain Visual Analog scale (from 0 to 10) | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| Comparaison of the PaO2/FiO2 ratio in both groups | Comparaison of the PaO2/FiO2 ratio in both groups | 1 hour after the end of the 1st non-invasive ventilation session |
| Comparaison of the incidence rate of respiratory aggravation in the 2 groups | Comparaison of the incidence rate of respiratory aggravation in the 2 groups | Until discharge from intensive care/continuous care or until maximum D7. |
| Rate of patients included in the experimental group in whom the use of ultrasound during the initiation of non-invasive ventilation is possible | Rate of patients included in the experimental group in whom the use of ultrasound during the initiation of NIV is possible | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| PaO2/FiO2 ratio in both groups in patients with pulmonary consolidation | PaO2/FiO2 ratio in both groups in patients with pulmonary consolidation | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| PaO2/FiO2 ratio in both groups in patients with pleural effusion | PaO2/FiO2 ratio in the 2 groups in patients with pleural effusion | at the 30th minute from the start of the 1st Non-invasive ventilation session |
| ID | Term |
|---|---|
| D013898 | Thoracic Injuries |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
Not provided
Not provided
| ID | Term |
|---|---|
| D001784 | Blood Gas Analysis |
| C034430 | methyl hydroxyethyl cellulose |
| ID | Term |
|---|---|
| D001774 | Blood Chemical Analysis |
| D019963 | Clinical Chemistry Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D012129 | Respiratory Function Tests |
| D003948 | Diagnostic Techniques, Respiratory System |
| D008919 | Investigative Techniques |
Not provided
Not provided